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The serological response of strain A mice to the hapten, p-azophenylarsonate (Ar), 
is dominated by the presence of a cross-reactive idiotype (Id  cR) originally defined by 
a  heterologous  (rabbit)  antiserum.  Administration  of this  antiserum  before Ar-im- 
munization resulted  in  an anti-Ar response that  lacked idiotype-positive (Id  +)  anti- 
bodies  (1). This  suppression  was  shown  to  be  associated  with  T  suppressor  cells 
capable of transferring the suppressed state to n~.ive, lightly irradiated recipients  (2). 
An apparent suppressed state could also be transferred by B cells, which suggests that 
relative inactivity or deletion of Id  + B cell clones occurred in Id-suppressed mice (3). 
It has been reported that monoclonal antiidiotopes,  as well as heterologous anti-Id, 
suppress  Id production in  the Ar system  (4,  5).  Further  understanding of Id  cR has 
resulted  from the construction of panels of Id  cR+ and Id  cR- Ar-binding hybridoma 
proteins  (HP).  Amino acid  sequence analysis of these  proteins  has shown that  the 
Id  cR consists of closely related but nonidentical sequences (6, 7). Recently it has been 
reported  that  the  amino acid sequence of the  heavy chain of the  Id  cR+ HP 36-65 
corresponds  precisely  to  the  germ  line  gene  for  the  Id  cR  family  (8).  Thus  Id  oR+ 
antibodies appear to represent a family of molecules derived from the HP 36-65 heavy 
chain variable (Vn) sequence through somatic diversification. 
We have now studied the distribution of two idiotopes expressed by the heavy chain 
of HP 36-65 and the properties of the two murine monoclonal antibodies that define 
these idiotopes. Among Id  cR+ HP and Ar-immune serum antibodies, the two idiotopes 
were not always expressed together. In view of the suggestion that Id  + sequences are 
involved  in  immunoregulation,  we  evaluated  the  fine  specificity  of  suppression 
induced by the two antiidiotopes. It seemed possible that (a) suppression induced by 
both reagents would be identical, because both of them react with the HP 36-65 germ 
line sequence; or (b)  suppression  induced by these reagents might be different and 
reflect the unlinked expression of the two idiotopes among diversified Id  cR+ molecules. 
Materials and Methods 
At-binding HP.  Monoclonal  antibodies  were produced  and purified as previously described 
(4). 
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Rabbit Antiidiotypic Antisera.  Rabbit PP.2  was immunized with A/J Ar-immune sera and 
then  boosted  with  HP  16-46  as described  (4).  Rabbit  A  was  immunized with  HP  36-65. 
Ammonium sulfate fractions of these antisera were absorbed to remove activity against normal 
mouse immunoglobulins (4), which yielded the antiidiotypic reagents, Rab-PP.2 and Rab-A, 
respectively. 
Marine Monoclonal Antiidiotope Reagents.  Hybrid cell lines resulted from fusion of SP2/O-Ag 
with spleen cells from BALB/c and A/J mice immunized with HP 36-65 (4). Secreted antibodies 
were  designated MB  (BALB/c fusion partner)  and  AI  (A/J  fusion partner).  MB  has been 
referred to as MB anti-Id  cR (4). Both AI and MB are IgGa, g antibodies. 
Radioimmunoassays.  Amounts  of Id and  anti-Ar antibodies were  quantified  as previously 
described  (4).  Ar-coupled tyrosine  for  the  assay  of hapten  inhibition  was  obtained  from 
Biosearch, San Rafael, CA. 
Immunoadsorbents.  AI and MB antiidiotopes were purified from ascites fluid by precipitation 
with 40% ammonium sulfate and coupled to cyanogen bromide-activated Sepharose 4B. 
Preparation of liP 36-65 Heavy ( H ), Light ( L ), and Recombined ( R ) chains.  H  and L chains of 
HP 36-65 were reduced with dithiothreitol, alkylated with iodoacetamide (9), and separated on 
an ACA 44 column equilibrated in 5 M  guanidine and 0.1 M sodium acetate, pH 5.5. Peak H 
and  L  fractions were dialyzed extensively against 0.01  M  sodium acetate, pH 5.5,  and then 
dialyzed against phosphate-buffered saline. Separated chains were recombined by mixing 1:1 
molar ratios of H  and L chains by optical density, in guanidine buffer, followed by dialysis as 
above. 
Animals.  6-8-wk-old male  A/J  mice were  obtained  from  The Jackson  Laboratory, Bar 
Harbor, ME. Rabbits were obtained from Margaret's Home Farm, Greenfield, MA. 
Induction of Suppression.  Adult A/J mice received either 0.2 cc 1  : 10 AI ascites, 0.1 cc 1  : 10 MB 
ascites, or 0.4 cc Rab-A intraperitoneally on day 1. Mice received five intraperitoneal immu- 
nizations with 0.1 mg Ar-keyhole limpet hemocyanin (KLH) on days 19, 33, 47, 61, and 76; the 
first two immunizations were emulsified in complete Freund's adjuvant, and the last three in 
incomplete Freund's adjuvant. Mice were bled on days 43 and 86. 
Results 
Hapten Inhibition of Antiidiotypic  Binding.  The concentrations of Ar-tyrosine required 
for 50%  inhibition of the binding of 125I-labeled HP  36-65 to polyvinyl wells coated 
with AI, MB, and Rab-A were 0.0166,  0.0647,  and 0.188  mM, respectively, Both AI 
and MB appear to identify epitopes at or near the combining site of HP 36-65, since 
<10 -4 M  hapten produced 50% inhibition of idiotope-antiidiotope binding. 
Fine Specificity of Antiidiotypic  Reagents.  The fine-specificity profiles of AI, MB, and 
Rab-A with respect to seven different Id  cR+ HP are shown in Table I, as indicated by 
the  ability of each  Id  cR+  HP  to  inhibit  the  binding  of  125I-labeled  HP  36-65  to 
polyvinyl wells coated with anti-Id. Rab-A recognized determinants on all of the HP 
identified  as  Id  eR+  by  Rab-PP.2.  The  monoclonal  antiidiotopes  displayed  more 
restricted specificity. MB  identified an epitope present on  five Id  cR+  HP  (IdMB). AI 
identified an epitope present on three Id  cR+ HP  (IdAI), all of which also expressed the 
MB epitope. Neither monoclonal-defined epitope was present on five Id  cR- HP (data 
not shown). 
Immunoadsorption ofAr-imrnune Sera.  A  pool of six Ar-immune sera was assayed for 
Id before and after depletion by AI and MB  immunoadsorbent columns  (Table II). 
Immunoadsorption  by  AI  resulted  in  the  loss  of molecules bearing  IdAX; however, 
some molecules bearing Id  M~  (in the absence of Id  AI) were still present. Immunoad- 
sorption by MB resulted in the loss of molecules bearing Id  MB as well as those bearing 
Id  AI. As suggested by the fine specificity with Id  cR+ HP, the AI idiotope appears to be 
more limited in its representation among anti-Ar antibodies from immune sera than ROTHSTEIN ET AL.  BRIEF  DEFINITIVE REPORT 
TABLE I 
Specificity of Antiidiotypic Reagents 
Inhibition by HP*  Antiidiotypie 
reagent  36-65  31-62  45-223  16-46  45-248  36-71  44-10 
Rab-PP.2  96  89  85  96  88  88  75 
Rab-A  94  59  34  73  36  46  50 
MB  96  96  75  92  34  9  1 
AI  89  79  51  11  0  0  0 
* Percent inhibition by 10 ng/well unlabeled HP of radiolabeled HP 36-65 which bound 
to each antiidiotypic reagent in solid-phase  radioimmunoassay. 
TABL~ II 
Specific Depletion of ld-bearing Antibodies by MB- and AI-coupled Immunoadsorbents 
797 
Id defined by various reagents*  Anti-Ar 
AI  MB  Rab-A  Rab-PP.2  antibody* 
Immune serum pool  278  341  405  1710  1740 
Depleted by MB  <2.0~  <1.0  11.3  290  610 
Depleted by AI  <2.0  7.3  17.7  304  888 
* Microgram equivalents of HP 36-65. 
:~ Below the limit of reliable detection; 1 h/well produced <50% inhibition. 
does the MB idiotope. Some immune antibodies bear Id  MB alone, without Id  AI, but 
there are no detectable antibodies that bear Id  AI without Id  MB. 
Location of the A! and MB Idiotopes.  L, H, and R chains (see Materials and Methods) 
were tested for their ability to compete with 125I-I-IP  36-65 for binding to immobilized 
AI, MB, and Rab-A. The results of two experiments are shown in Table III and are 
expressed  as  a  percent  of unlabeled  HP  36-65  activity determined  simultaneously. 
The determinants on HP 36-65 that were recognized by all three anti-Id were shared 
by material in the 36-65 R  fraction, whereas the 36-65 L chains failed to compete for 
binding to any of the anti-Id. HP 36-65 determinants recognized by AI and MB were 
shared by 36-65 H  chains; for MB, 36-65 H  chains appeared to compete for binding 
almost as well  as  R  chains on a  microgram for microgram basis.  The determinant 
recognized by Rab-A was different in that it was not shared by 36-65 H  chains. This 
latter result indicates that the binding of AI and MB to 36-65 H  chains did not result 
from L chain contamination of the H  chain preparation. 
Fine Specificity of Suppression Induced by AI,  MB,  and Rab-A.  Adult A/J male mice 
received anti-Id and Ar-KLH as described in Materials and Methods. Mice were bled 
after two and again after five immunizations and the sera were assayed for titers of 
idiotopic and idiotypic determinants.  Results from the second bleeding are shown in 
Table IV and are reported as microgram equivalents of HP 36-65 per milliliter.  Six 
of seven mice that received MB failed to express Id  MB, and all of these mice failed to 
express Id  AI. On the other hand, seven of seven mice that received AI failed to express 
Id  AI but six of them produced anti-Ar antibodies that expressed Id  MB. Thus, Id  MB+ 
Id  AI- antibodies were not suppressed  by prior administration  of AI (nor were they 
depleted  by immunoadsorption with AI; see  Table  II). Both groups of mice made 
antibodies that expressed the Rab-A and Rab-PP.2 determinants. 
Five of five mice that received Rab-A failed to express the Rab-A determinant, and 
all of these mice failed to express the AI and MB idiotopes as well, which is consistent 798  ROTttSTEIN  ET  AI,.  BRIEF  DEFINITIVE  REPORT 
TABLE III 
Idiotypic Activity of Separated HP 36-65 H  and L  Chains 
Experiment  1  Experiment  2 
AI  MB  Rab-A  AI  MB  Rab-A 
HP 36-65  100"  100  100  100  100  100 
36-65  L~/  1.5  0.68  0.95  0.94  0.56  0.22 
36-65  H:~  38  54  3.3  21  61  1.3 
36-65  R:~  97  63  64  49  69  35 
* Micrograms  per  well  required  for  50'~  inhibition  is  expressed  as  percent  HP  36-65 
activity, 
~: L, H, and R chains were prepared  as described  in Materials and  Methods. 
TABLE IV 
Specific Suppression of ld-bearing Antibodies by Prior Immunization with A1, 
MB, and Rab-A Antiidiotypic Reagents 
ld defined by various reagents*  Anti-AR 
Anti-Id 
AI  MB  Rab-A  Rab-PP.2  antibody* 
AI  <1.0~/  24.6  25.3  722  1,200 
< 1.0  17 4  176  1,040  2,470 
< 1.0  41).3  370  2,230  7,420 
< 1.0  4.2  232  1.880  2,9311 
< 1.0  7.0  15.0  303  2,640 
< 1.0  7.6  6 8  517  4 280 
<1.0  <2.4  323  3,160  3,700 
M B  < 1.0  < 1.0  336  1.200  3,180 
<2.5§  13.8  114  2,377  7,7211 
<1.0  <2.4  226  1,910  3,240 
< 1.0  < 1.0  < 1.0  30.4  6,700 
<  1.0  < 1.0  3.0  4(17  3,680 
<  1.0  < 1.0  170  1,830  5,170 
< 1.0  < 1.0  10.6  513  2,030 
Rab-A  < 1.0  <2.4  < 1  0  3.6  4,470 
<  1.0  < 1.0  < 1  0  < 1.0  4,250 
< 1.0  < 1.0  < 1.0  1.6  1,840 
< 1.0  < 1.0  < 1.0  < 1.0  3,890 
< 1.0  < 1.0  < 1 0  102  1,230 
* Microgram equivalents of HP 36-65  per milliliter; each line represents results on a single 
mouse. 
Below the limit of reliable detection;  1 X/well failed to produce any significant inhibition 
and  thus contained  <1  ng equivalents  of HP 36-65 
§ Below  the  limit  of reliable  detection;  1 X/well  produced  <50~  inhibition,  and  thus 
contained  <2.5 ng equivalents  of HP 36-65). 
with  the  specificities  of these  reagents.  Results  from the  first  bleeding  (not  shown) 
were similar to those described above. 
Discussion 
We examined the fine specificity of Id suppression induced by two hapten-inhibit- 
able monoclonal antiidiotopes that identify different epitopes on the H  chain of HP 
36-65,  an Ar-binding  protein whose sequence is found in the germ line of A/J  mice 
(8). Reactivity of the antiidiotopes toward a panel of Ar-binding HP and immunoad- 
sorption  of Ar-immune  sera  by  the  antiidiotopes  demonstrated  that  one  idiotope 
(Id AI)  is found on a  subset of molecules that  bear  the other  (IdMB), which indicates ROTHSTEIN  ET AL.  BRIEF  DEFINITIVE REPORT  799 
that there are Id  MB+ Id  AI- molecules among diversified Id  ca+ HP and serum antibod- 
ies.  In  vivo administration  of the  antiidiotopes  led  to  the  deletion  of nonidentical 
portions  of the  Ar-immune  response;  immune  sera  from  mice suppressed  with  AI 
failed to express Id  AI but continued to express Id  MB, whereas sera from mice suppressed 
with MB were suppressed for both the AI and MB idiotopes. Thus, suppression was 
idiotope-specific and corresponded to the fine specificities of the antiidiotope antibod- 
ies. 
Nelles et al. (5) reported that two murine monoclonal antiidiotopes suppressed most 
of the  Id  cR+  antibody  response  when  administered  before  Ar-immunization.  The 
present study extends these findings by examining the idiotope expression of anti-Ar 
antibodies that escaped such suppression. The present finding of idiotope specificity 
in antiidiotope-mediated suppression is consistent with earlier reports in the T15 (10) 
and NP  b (11) Id systems in which there was nonreciprocal variation in the expression 
of two idiotopes during antiidiotope-induced immunoregulation. 
The most straightforward  explanation  for the  present  results  is  that  homologous 
antiidiotope  exerts  its  effect  through  direct  binding  to  diversified  B  cell  surface 
immunoglobulin.  Mechanisms  that  involve  receptor  blockade  (12)  or  tolerogenic 
signals  (13)  might  initiate  suppression  that  is  subsequently  perpetuated  by clonal 
dominance of idiotope-negative B  cells  (3).  The induction  of a  suppressive network 
via complexes with serum Id (as found in immune sera or in undiversified germ line 
sequences)  seems unlikely because interaction  with  any intermediate  that  expresses 
the AI and MB idiotopes together would result in parallel effects upon both idiotopes, 
unless  antiidiotope  were able to  "activate" only the  occupied  idiotope  for network 
interactions  in a  molecule expressing both idiotopes.  Because both the AI and MB 
idiotopes are represented in a single germ line gene that encodes Id, the mediation of 
suppression by regulatory T  lymphocytes in which  VH is the T  cell receptor would 
seem unlikely under the assumpiton that  both idiotopes are represented within  the 
VH  segment  and  are  unaffected  by  D-region  segments.  Alternatively,  sufficient 
diversity in T cell receptors may exist such that the AI and MB idiotopes are expressed 
separately,  leading  to  activation  of separate  sets  of idiotope-specific  regulatory  T 
lymphocytes. Regardless of the  mechanism, the  present  results  do not  rule out  the 
participation  by T  lymphocytes, assuming that suppressor cells,  after activation by 
antiidiotope,  retain idiotope specificity and induce suppression that does not spread 
to other closely related idiotopes over a relatively long period of time (3 too). 
Id  oR+ antibodies  appear to result  from somatic diversification away from a  germ 
line gene (8). Although the single germ line sequence for Id (defined by conventional 
rabbit  antisera)  contains both  the AI and MB  idiotopes,  antiidiotope-induced  sup- 
pression  was  not  identical;  moreover,  Id  cR+,  idiotope-negative  sequences  escaped 
suppression. This suggests that these sequences (as well as Id  MB÷ Id  AI- sequences) had 
diversified away from the germ line sequence before administration  of the antigen. 
The possibility that  the  Id  eR+, idiotope-negative molecules correspond to the germ 
line VH combined with a distinct D region cannot be ruled out. Examination ofld ca+, 
idiotope-negative liP isolated from idiotope-suppressed mice may clarify this point. 
Summary 
Two hapten-inhibitable murine monoclonal antiidiotopic antibodies identified two 
idiotopes  expressed by the  heavy chain  of hybridoma protein  36-6.5, whose  amino 800  ROTHSTEIN  ET AL.  BRIEF  DEFINITIVE  REPORT 
acid sequence is encoded in the germ line of A/J mice. Among cross-reactive idiotype- 
positive hyhridoma proteins and p-azophenylarsonate-immune antibodies, the  two 
idiotopes were not always expressed together;  some diversified antibodies expressed 
one idiotope without the other. Suppression that was induced by the two antiidiotopes 
was idiotope specific and corresponded to the fine specificities of these two reagents. 
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